Aranscia

February 28th is #RareDiseaseDay. Rare diseases affect 300 million people worldwide - many of which are genetic. Learn more about the awareness day and how to get involved at www.rarediseaseday.org #RareDiseases #MoreThanYouCanImagine #Genetics #GeneticTesting

"First, if we go back to the case of DPYD testing, for example... there is lack of education or knowledge among the community—including the oncology care team—that these tests are available, that we have tools, have established guidelines, that there are standards, and therefore they are ready for implementation." - Houda Hachad, Vice President of Clinical Operations at Aranscia Read more about Houda's insights on best practices for implementing PGx testing in oncology in the Journal of Clinical Pathways: https://lnkd.in/dXi2E-tG #PGx #Pharmacogenomics #JournalofClinicalPathways #HoudaHachad #DrHoudaHachad #Aranscia

"PGx programs were traditionally aligned and concentrated in their studied impact on pharmacy, but as time has progressed, study after study has confirmed PGx programs’ strong economic benefits – including their ability to reduce overall health care costs and utilization." - Joe Spinelli, Chief Strategy Officer at Aranscia Read more about Joe's predictions for precision medicine in 2025 in Electronic Health Reporter: https://lnkd.in/gxwaMuGf #PGx #Pharmacogenomics #JoeSpinelli

Happy Valentine's Day, from our team to yours ?? #Aranscia #ValentinesDay

The impact of Fluoropyrimidines-induced severe toxicity can no longer be overlooked. Preemptive genetic testing for DPYD pathogenic variants must become standard practice to identify at-risk patients and prevent life-threatening complications, positioning DPYD testing as a public health priority. - Houda Hachad, VP of Clinical Operations at Aranscia Learn more about DPYD testing in "Recommendations for Standardizing DPYD Pharmacogenomic Testing" - an interview between Houda Hachad and the Journal of Clinical Pathways. Click the link below to read the full article: https://lnkd.in/eS7U6HiX #DPYD #Pharmacogenomics #PGx #FDA #HoudaHachad

February is American Heart Month ??? ?? With heart disease being the leading cause of death in the United States, we at Aranscia want to help bring awareness to the importance of heart health. Learn more about risk, prevention, and education from NHLBI – Heart Research & Education or by visiting https://lnkd.in/gmTBQiiq #OurHearts #AmericanHeartMonth #Cardiology

" We can now confidently transform experimental PGx programs into comprehensive PGx hubs for larger patient communities.?We will see amplification in the use of PGx test results by healthcare providers to elevate their therapeutic decisions and select effective interventions sooner." - Houda Hachad, PharmD, M. Res, Vice President of Clinical Operations at Aranscia Read more about Houda's predictions for 2025 in DOTmed's article, "Seven healthcare execs share their 2025 predictions." https://lnkd.in/gTeQ6eah #HoudaHachad #DOTmed

On National Pharmacist Day, Aranscia celebrates all pharmacists who play a vital role in healthcare and precision medicine. Their expertise ensures safer, personalized treatments and better patient outcomes. #NationalPharmacyDay

"Workflow optimization and machine learning-process tools may appear to be the lowest hanging fruit towards care efficiency, but a growing number of solutions including proactive risk screenings, chronic disease management, and personalized medication management are showing incredible benefit when effectively implemented into a connected population and provider universe." - Joe Spinelli, Chief Strategy Officer at Aranscia Read more about Joe's predictions for 2025, as well as the predictions of many other industry experts, in Health IT Answers: https://lnkd.in/eqsUm3hJ

"As predicted, the health care industry saw many advancements in precision oncology in 2024, driven by consumer demand for genetic testing to assess cancer risk." - Dr. Joel Diamond, MD, Chief Medical Officer at Aranscia Read more of Joel's thoughts on what happened in 2024 and what could come in 2025 in Population Health Learning Network's First Report Managed Care: #Aranscia #DrJoelDiamond #PHLN